🇺🇸 FDA
Patent

US 10814010

FOXC2 inhibitor and methods of use thereof

granted A61KA61K31/5377A61P

Quick answer

US patent 10814010 (FOXC2 inhibitor and methods of use thereof) held by The Board of Regents of the University of Texas System expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/5377, A61P, A61P35/04